Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Domestication of cattle: Two or three events?

Pitt D, Sevane N, Nicolazzi EL, MacHugh DE, Park SDE, Colli L, Martinez R, Bruford MW, Orozco-terWengel P.

Evol Appl. 2018 Jul 23;12(1):123-136. doi: 10.1111/eva.12674. eCollection 2019 Jan.

2.

Demography and rapid local adaptation shape Creole cattle genome diversity in the tropics.

Pitt D, Bruford MW, Barbato M, Orozco-terWengel P, Martínez R, Sevane N.

Evol Appl. 2018 May 18;12(1):105-122. doi: 10.1111/eva.12641. eCollection 2019 Jan.

3.

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA.

Brain. 2019 Jan 1;142(1):133-145. doi: 10.1093/brain/awy296.

PMID:
30561514
4.

Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis.

Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, Sumida T, Airas L, Zhang S, Isitan C, Nguyen TD, Raine CS, Hafler DA, Pitt D.

Nat Commun. 2018 Dec 17;9(1):5337. doi: 10.1038/s41467-018-07785-8.

5.
6.

Astrocytes play a crucial role in the formation and evolution of MS lesions - Yes.

Pitt D, Ponath G.

Mult Scler. 2019 Jan;25(1):15-17. doi: 10.1177/1352458518793026. Epub 2018 Aug 23. No abstract available.

PMID:
30136895
7.

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Deh K, Ponath GD, Molvi Z, Parel GT, Gillen KM, Zhang S, Nguyen TD, Spincemaille P, Ma Y, Gupta A, Gauthier SA, Pitt D, Wang Y.

J Magn Reson Imaging. 2018 Nov;48(5):1281-1287. doi: 10.1002/jmri.25997. Epub 2018 Mar 8.

PMID:
29517817
8.

Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.

Gillen KM, Mubarak M, Nguyen TD, Pitt D.

Front Immunol. 2018 Feb 19;9:255. doi: 10.3389/fimmu.2018.00255. eCollection 2018. Review.

9.

The Role of Astrocytes in Multiple Sclerosis.

Ponath G, Park C, Pitt D.

Front Immunol. 2018 Feb 19;9:217. doi: 10.3389/fimmu.2018.00217. eCollection 2018. Review.

10.

Myeloid cell plasticity in the evolution of central nervous system autoimmunity.

Giles DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, Ponath G, Pitt D, Segal BM.

Ann Neurol. 2018 Jan;83(1):131-141. doi: 10.1002/ana.25128. Epub 2018 Jan 14.

11.

My Latin teacher: response to the editorial "Datum isn't, data are".

Pitt DF.

Can J Surg. 2017 Oct;60(5):E4. No abstract available.

12.

Podoplanin is a negative regulator of Th17 inflammation.

Nylander AN, Ponath GD, Axisa PP, Mubarak M, Tomayko M, Kuchroo VK, Pitt D, Hafler DA.

JCI Insight. 2017 Sep 7;2(17). pii: 92321. doi: 10.1172/jci.insight.92321. eCollection 2017 Sep 7.

13.

Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH, Gupta A, Tsiouris AJ, Kovanlikaya I, Chiang GC, Weinsaft JW, Tanenbaum L, Chen W, Zhu W, Chang S, Lou M, Kopell BH, Kaplitt MG, Devos D, Hirai T, Huang X, Korogi Y, Shtilbans A, Jahng GH, Pelletier D, Gauthier SA, Pitt D, Bush AI, Brittenham GM, Prince MR.

J Magn Reson Imaging. 2017 Oct;46(4):951-971. doi: 10.1002/jmri.25693. Epub 2017 Mar 10. Review.

14.

Informed consent for surgery: risk discussion and documentation.

Hanson M, Pitt D.

Can J Surg. 2017 Feb;60(1):69-70.

15.

Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.

Ponath G, Ramanan S, Mubarak M, Housley W, Lee S, Sahinkaya FR, Vortmeyer A, Raine CS, Pitt D.

Brain. 2017 Feb;140(2):399-413. doi: 10.1093/brain/aww298. Epub 2016 Dec 21.

16.

Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.

Zhang Y, Gauthier SA, Gupta A, Chen W, Comunale J, Chiang GC, Zhou D, Askin G, Zhu W, Pitt D, Wang Y.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1629-35. doi: 10.3174/ajnr.A4825. Epub 2016 Jun 2.

17.

Ancient and modern DNA reveal dynamics of domestication and cross-continental dispersal of the dromedary.

Almathen F, Charruau P, Mohandesan E, Mwacharo JM, Orozco-terWengel P, Pitt D, Abdussamad AM, Uerpmann M, Uerpmann HP, De Cupere B, Magee P, Alnaqeeb MA, Salim B, Raziq A, Dessie T, Abdelhadi OM, Banabazi MH, Al-Eknah M, Walzer C, Faye B, Hofreiter M, Peters J, Hanotte O, Burger PA.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6707-12. doi: 10.1073/pnas.1519508113. Epub 2016 May 9.

18.

CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment.

Cao Y, Nylander A, Ramanan S, Goods BA, Ponath G, Zabad R, Chiang VL, Vortmeyer AO, Hafler DA, Pitt D.

Neurology. 2016 Apr 19;86(16):1553-6. doi: 10.1212/WNL.0000000000002594. Epub 2016 Mar 16. No abstract available.

19.

Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation.

Gupta S, Gouw L, Wright J, Chawla S, Pitt D, Wade M, Boucher K, Sharma S.

Invest New Drugs. 2016 Apr;34(2):243-52. doi: 10.1007/s10637-016-0333-z. Epub 2016 Feb 20.

PMID:
26897615
20.

Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.

Guerau-de-Arellano M, Liu Y, Meisen WH, Pitt D, Racke MK, Lovett-Racke AE.

J Autoimmune Disord. 2015;1(1). pii: 6.

21.

Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping.

Stüber C, Pitt D, Wang Y.

Int J Mol Sci. 2016 Jan 14;17(1). pii: E100. doi: 10.3390/ijms17010100. Review.

22.

Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.

Schmalbrock P, Prakash RS, Schirda B, Janssen A, Yang GK, Russell M, Knopp MV, Boster A, Nicholas JA, Racke M, Pitt D.

AJNR Am J Neuroradiol. 2016 Mar;37(3):439-46. doi: 10.3174/ajnr.A4599. Epub 2015 Nov 26.

23.

Biomarkers in multiple sclerosis.

Housley WJ, Pitt D, Hafler DA.

Clin Immunol. 2015 Nov;161(1):51-8. doi: 10.1016/j.clim.2015.06.015. Epub 2015 Jul 2. Review.

PMID:
26143623
24.

Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration.

Orack JC, Deleidi M, Pitt D, Mahajan K, Nicholas JA, Boster AL, Racke MK, Comabella M, Watanabe F, Imitola J.

Stem Cells Transl Med. 2015 Mar;4(3):252-60. doi: 10.5966/sctm.2014-0133. Epub 2015 Jan 15. Review.

25.

Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.

Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D.

Magn Reson Med. 2015 Aug;74(2):564-70. doi: 10.1002/mrm.25420. Epub 2014 Aug 18.

26.

B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.

Stern JN, Yaari G, Vander Heiden JA, Church G, Donahue WF, Hintzen RQ, Huttner AJ, Laman JD, Nagra RM, Nylander A, Pitt D, Ramanan S, Siddiqui BA, Vigneault F, Kleinstein SH, Hafler DA, O'Connor KC.

Sci Transl Med. 2014 Aug 6;6(248):248ra107. doi: 10.1126/scitranslmed.3008879.

27.
28.

Quantitative susceptibility mapping of multiple sclerosis lesions at various ages.

Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, Pei M, Pitt D, Wang Y.

Radiology. 2014 Apr;271(1):183-92. doi: 10.1148/radiol.13130353. Epub 2013 Nov 18.

29.

Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.

Cox GM, Kithcart AP, Pitt D, Guan Z, Alexander J, Williams JL, Shawler T, Dagia NM, Popovich PG, Satoskar AR, Whitacre CC.

J Immunol. 2013 Aug 1;191(3):1043-54. doi: 10.4049/jimmunol.1200485. Epub 2013 Jun 24.

30.

Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, Schmalbrock P, Pitt D.

PLoS One. 2013;8(3):e57573. doi: 10.1371/journal.pone.0057573. Epub 2013 Mar 14.

31.

Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.

Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D.

JAMA Neurol. 2013 Mar 1;70(3):398-402. doi: 10.1001/jamaneurol.2013.1960. Review.

PMID:
23338729
32.

Joseph Lister: father of modern surgery.

Pitt D, Aubin JM.

Can J Surg. 2012 Oct;55(5):E8-9. No abstract available.

33.

Detecting cortical lesions in multiple sclerosis at 7 T using white matter signal attenuation.

Bluestein KT, Pitt D, Sammet S, Zachariah CR, Nagaraj U, Knopp MV, Schmalbrock P.

Magn Reson Imaging. 2012 Sep;30(7):907-15. doi: 10.1016/j.mri.2012.03.006. Epub 2012 May 11.

34.

The script concordance test as a measure of clinical reasoning: a national validation study.

Nouh T, Boutros M, Gagnon R, Reid S, Leslie K, Pace D, Pitt D, Walker R, Schiller D, MacLean A, Hameed M, Fata P, Charlin B, Meterissian SH.

Am J Surg. 2012 Apr;203(4):530-4. doi: 10.1016/j.amjsurg.2011.11.006.

PMID:
22450028
35.

Evidence for a volatile pheromone in Agrilus planipennis Fairmaire (Coleoptera: Buprestidae) that increases attraction to a host foliar volatile.

Silk PJ, Ryall K, Mayo P, Lemay MA, Grant G, Crook D, Cossé A, Fraser I, Sweeney JD, Lyons DB, Pitt D, Scarr T, Magee D.

Environ Entomol. 2011 Aug;40(4):904-16. doi: 10.1603/EN11029.

PMID:
22251692
36.

New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.

Nicholas J, Morgan-Followell B, Pitt D, Racke MK, Boster A.

J Cent Nerv Syst Dis. 2012 May 16;4:81-103. doi: 10.4137/JCNSD.S6692. Print 2012.

37.

Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.

Boster A, Bartoszek MP, O'Connell C, Pitt D, Racke M.

Ther Adv Neurol Disord. 2011 Sep;4(5):319-32. doi: 10.1177/1756285611422108.

38.

T1 and proton density at 7 T in patients with multiple sclerosis: an initial study.

Bluestein KT, Pitt D, Knopp MV, Schmalbrock P.

Magn Reson Imaging. 2012 Jan;30(1):19-25. doi: 10.1016/j.mri.2011.07.018. Epub 2011 Sep 19.

39.

What happens when natalizumab therapy is stopped?

Schaaf SM, Pitt D, Racke MK.

Expert Rev Neurother. 2011 Sep;11(9):1247-50. doi: 10.1586/ern.11.109.

PMID:
21864070
40.

Role of personal decontamination in preventing the spread of equine influenza.

Frazer JL, Perkins NR, Pitt D.

Aust Vet J. 2011 Jul;89 Suppl 1:120-4. doi: 10.1111/j.1751-0813.2011.00763.x.

PMID:
21711308
41.

Significant features of the epidemiology of equine influenza in Queensland, Australia, 2007.

Kung N, Mackenzie S, Pitt D, Robinson B, Perkins NR.

Aust Vet J. 2011 Jul;89 Suppl 1:78-85. doi: 10.1111/j.1751-0813.2011.00781.x.

PMID:
21711297
42.

TMDL implementation in agricultural landscapes: a communicative and systemic approach.

Jordan NR, Slotterback CS, Cadieux KV, Mulla DJ, Pitt DG, Olabisi LS, Kim JO.

Environ Manage. 2011 Jul;48(1):1-12. doi: 10.1007/s00267-011-9647-y. Epub 2011 Mar 10.

PMID:
21547434
43.

The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis.

Imagawa K, de Andrés MC, Hashimoto K, Pitt D, Itoi E, Goldring MB, Roach HI, Oreffo RO.

Biochem Biophys Res Commun. 2011 Feb 18;405(3):362-7. doi: 10.1016/j.bbrc.2011.01.007. Epub 2011 Jan 8.

44.

Assessing the impact of suicide exclusion periods on life insurance.

Yip P, Pitt D, Wang Y, Wu X, Watson R, Huggins R, Xu Y.

Crisis. 2010;31(4):217-23. doi: 10.1027/0027-5910/a000023.

PMID:
20801752
45.

Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging.

Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, Rammohan K, Knopp MV, Schmalbrock P.

Arch Neurol. 2010 Jul;67(7):812-8. doi: 10.1001/archneurol.2010.148.

PMID:
20625086
46.

Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity.

Pitt D, Gonzales E, Cross AH, Goldberg MP.

Brain Res. 2010 Jan 14;1309:146-54. doi: 10.1016/j.brainres.2009.10.066. Epub 2009 Nov 4.

PMID:
19896473
47.

Electrophysiological response and attraction of emerald ash borer to green leaf volatiles (GLVs) emitted by host foliage.

de Groot P, Grant GG, Poland TM, Scharbach R, Buchan L, Nott RW, Macdonald L, Pitt D.

J Chem Ecol. 2008 Sep;34(9):1170-9. doi: 10.1007/s10886-008-9514-3. Epub 2008 Jul 4.

PMID:
18600378
48.

Professionalism--connecting the past and the present and a blueprint for the Canadian Association of General Surgeons.

Christian F, Pitt DF, Bond J, Davison P, Gomes A; Committee on Professionalism, Canadian Association of General Surgeons, Bond J.

Can J Surg. 2008 Apr;51(2):88-91. No abstract available.

49.

A seroepidemiological study of bovine pestivirus in Queensland beef and dairy herds conducted in 1994/95.

Taylor LF, Black PF, Pitt DJ, Mackenzie AR, Johnson SJ, Rodwell BJ.

Aust Vet J. 2006 May;84(5):163-8.

PMID:
16739525
50.

Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.

Pitt D, Nagelmeier IE, Wilson HC, Raine CS.

Neurology. 2003 Oct 28;61(8):1113-20.

PMID:
14581674

Supplemental Content

Support Center